Treatment Considerations for Patent Foramen Ovale-Associated Stroke

Author(s): Shaffer Rose

Contact Hours 1.00

CERP A 1.00

Expires Dec 31, 2026

Topics: Cardiovascular, Medication Management, Neurology

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

The foramen ovale serves a vital role in utero, allowing blood to flow from the right atrium to the left atrium to bypass the baby’s immature lungs. While it usually closes after birth, in 25% of the adult population it has not; this is referred to as a patent foramen ovale (PFO). A PFO can cause an ischemic stroke. This foundational session focuses on how a PFO causes a stroke, treatment options for these patients and the nursing care for patients undergoing percutaneous closure.

Objectives

  • Define what a PFO is and the etiology of stroke in a person with a PFO.
  • Identify the factors which would favor closure of a PFO in a patient who had a stroke versus medication therapy.
  • Describe the nursing care for a patient undergoing percutaneous placement of a PFO closure device.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.